EVOKE PHARMA INC - COM (EVOK) Institutional Ownership

CUSIP: 30049G104

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2022

Type / Class
Equity / COM
Symbol
EVOK on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 30049G104?
CUSIP 30049G104 identifies EVOK - EVOKE PHARMA INC - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of EVOKE PHARMA INC - COM (EVOK) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2022 Q2 0 $0 -$987,030 0
2022 Q1 1,997,512 $987,030 -$33,393 $0.49 18
2021 Q4 2,045,575 $1,129,033 -$2,770,733 $0.55 20
2021 Q3 4,203,343 $5,463,078 -$391,583 $1.30 20
2021 Q2 4,504,481 $6,170,082 +$218,734 $1.37 19
2021 Q1 4,280,137 $7,833,000 +$2,685,816 $1.83 24
2020 Q4 2,613,871 $6,744,000 +$1,883,656 $2.58 26
2020 Q3 1,862,922 $8,738,000 +$2,219,549 $4.69 25
2020 Q2 1,400,544 $4,957,000 +$658,828 $3.54 18
2020 Q1 1,457,285 $1,689,000 +$54,501 $1.16 14
2019 Q4 1,453,598 $2,354,000 +$13,748 $1.62 15
2019 Q3 1,484,056 $1,275,000 +$226,175 $0.86 17
2019 Q2 1,278,062 $798,000 -$444,915 $0.62 17
2019 Q1 1,721,798 $2,554,000 -$3,965,122 $1.50 21
2018 Q4 3,189,935 $7,910,000 -$250,195 $2.48 19
2018 Q3 3,233,329 $9,639,000 +$211,874 $2.98 20
2018 Q2 3,168,901 $7,922,000 +$2,300,187 $2.50 20
2018 Q1 2,287,040 $4,756,000 -$1,210,619 $2.08 20
2017 Q4 2,852,722 $6,444,000 +$1,597,569 $2.26 26
2017 Q3 2,102,190 $7,021,000 +$495,294 $3.34 21
2017 Q2 1,980,641 $5,072,000 +$447,296 $2.56 20
2017 Q1 1,800,168 $5,580,000 +$3,895,639 $3.10 22
2016 Q4 585,704 $1,184,000 -$140,128 $2.02 14
2016 Q3 633,086 $1,428,000 -$810,060 $2.25 12
2016 Q2 446,273 $3,055,000 +$417,603 $6.84 13
2016 Q1 386,158 $1,965,000 -$113,505 $5.08 11
2015 Q4 418,252 $1,379,000 -$297,500 $3.30 14
2015 Q3 510,722 $1,491,000 +$135,598 $2.91 9
2015 Q2 459,614 $2,402,000 -$148,069 $5.22 12
2015 Q1 472,111 $3,309,000 +$480,110 $7.00 11
2014 Q4 404,253 $2,410,000 +$35,484 $5.90 11
2014 Q3 404,806 $2,226,367 -$402,087 $5.49 11
2014 Q2 409,268 $3,289,000 -$24,457 $8.09 9
2014 Q1 411,914 $3,447,000 +$2,296,444 $8.33 10